[The influence of verapamil on platelet function in patients with multiple myeloma].
Influence of verapamil on platelet function was evaluated in 7 female and 8 male patients with myeloma. The inhibitory effect on platelet aggregation and other parameters was documented in clinical observation.
Sokołowska
B
B
Kliniki Hematologii Akademii Medycznej w Lublinie.
Dmoszyńska
A
A
Walter-Croneck
A
A
Wojtaszko
M
M
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002330:Carmustine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood* / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D014700:Verapamil / Q000008:administration & dosage*; D014750:Vincristine / Q000008:administration & dosage
D010975:Platelet Aggregation Inhibitors; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D014700:Verapamil; D008558:Melphalan; D002330:Carmustine; D011241:Prednisone
Wpływ werapamilu na czynność krwinek płytkowych u chorych na szpiczaka plazmocytowego.